ir.wuxiapptec.com
WuXi AppTec: Investor Relations - IR HomeWuXi AppTec
http://ir.wuxiapptec.com/
WuXi AppTec
http://ir.wuxiapptec.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
16x16
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
1
SITE IP
23.12.41.8
LOAD TIME
0 sec
SCORE
6.2
WuXi AppTec: Investor Relations - IR Home | ir.wuxiapptec.com Reviews
https://ir.wuxiapptec.com
WuXi AppTec
Process Calendar
http://ir.wuxiapptec.com/ProcessCalendarRequest.asp?eventId=5200209&OverridePage=irol-EventDetails&checkJS=false
TOTAL PAGES IN THIS WEBSITE
1
Investor Relations | Wright Medical Technology
Wright Medical Group N.V. is a global medical device company focused on Extremities and Biologics. The company is committed to delivering innovative, value-added solutions improving quality of life for patients worldwide and is a recognized leader of surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets, three of the fastest growing segments in orthopaedics. January 9, 2017. 160;at 7:30 am PT. December 12, 2016. Wright Med...
Investor Overview | WEX Inc.
Washington, D.C. National Joint Powers Alliance. Select your account type:. WEX Inc at KBW Cards, Payments and Financial Technology Conference. 160;at 2:35 pm ET. Q1 2015 WEX Inc Earnings Conference Call. 160;at 10:00 am ET. WEX Inc at Jefferies Global Technology, Media and Telecom Conference. 160;at 2:30 pm ET. WEX Inc at J.P. Morgan Global Technology, Media and Telecom Conference. 160;at 2:50 pm ET. WEX Inc at William Blair and Company LLC Growth Stock Conference. 160;at 2:20 pm ET. 160; 1.84. WEX virt...
IRWeblink
Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.
Institutional Research | Washington State University
Skip to main content. 8211; Applications and Admissions. 8211; New Student Enrollment. 8211; Overall Enrollment. 8211; Retention, Graduation, and GPA. 8211; Historical (prior to 2012). Faculty and Staff Data. Finance and Research Expenditure Data. Common Data Set (CDS). OBIEE Data Warehouse (myWSU). National Resources in Higher Education. Guidelines for Teacher Assignment. Student Records Update part 2. IPEDs and Peer Comparisons. Delaware Study of Instructional Costs. Census Day Enrollment Reports.
W&T Offshore Inc. | Investor Relations
Founded in 1983, W&T is an independent oil and natural gas acquisition, exploitation and exploration company, with a focus primarily in the Gulf of Mexico. Our outstanding technical expertise combined with the high production rates associated with hydrocarbon deposits in the Gulf have historically provided us excellent opportunities to achieve a rapid payback on our invested capital. W&T became a public company in 2005 and trades on the NYSE under the symbol "WTI . 160;04 (10.84%). Read More ».
WuXi AppTec: Investor Relations - IR Home
Q2 2015 WuXi PharmaTech (Cayman) Inc. Earnings Conference Call. 160;at 8:00 am ET. Q2 2015 WuXi PharmaTech (Cayman) Inc. Earnings Conference Call. Friday, August 14, 2015 . 8:00 am ET . Click here for webcast. Click here to add this event to your calendar. WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release. WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement. 08/14/15 8:00 am ET. Enter your e-mail address . 160; 0.15. This calen...
WuXi AppTec: Investor Relations - IR Home
Q2 2015 WuXi PharmaTech (Cayman) Inc. Earnings Conference Call. 160;at 8:00 am ET. Q2 2015 WuXi PharmaTech (Cayman) Inc. Earnings Conference Call. Friday, August 14, 2015 . 8:00 am ET . Click here for webcast. Click here to add this event to your calendar. WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release. WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement. 08/14/15 8:00 am ET. Enter your e-mail address . 160; 0.15. This calen...
Press Releases | Xcel Brands, Inc.
Skip to main navigation. Mar 29, 2018. Xcel Brands, Inc. Announces Fourth Quarter 2017 Financial Results. NEW YORK , March 29, 2018 (GLOBE NEWSWIRE) - Xcel Brands, Inc. (NASDAQ:XELB) ( Xcel or the Company ), a consumer products company, today announced its financial results for the fourth quarter and full year ended December 31, 2017 . Robert W. D'Loren, Chairman and Chief Executive Officer of Xcel. Mar 22, 2018. Xcel Brands to Report Fourth Quarter 2017 Financial Results on March 29, 2018. Mar 13, 2018.
Xenetic - Investor Relations
Annual Reports and Proxies. Scheme and Related Documents. Xenetic Biosciences, Inc. (OTCQB: XBIO) is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics. Xenetics proprietary drug technology platforms include PolyXen for the development of next generation biologic drugs that extend the efficacy, safety and half-life of biologic drugs and OncoHist™ for the development of novel oncology drugs focused on orphan indications. Xenetic is working with Baxter Int...
Xenia IR
Is a hi-tech investment company publicly traded in the Tel Aviv Stock Exchange (TASE). Xenia is engaged in investing in early stage companies in the areas of high tech and med tech in Israel. Xenia also holds 50% of VLX. A technological incubator operating under the incubator program of the Office of the Chief Scientist of the State of Israel ( OCS. Mature, diversified, growing, quality portfolio. Strategic partnerships with leading international organizations. Leverage on robust IPO markets. June 2, 2015.
ir.xiaoyouxi_360_cn.uqdre.byjg.club
sb博彩公司是哪国的,葡京网登录不上,皇城娱乐城在线博彩-网上 盈丰 娱乐城